Incidence, risk factors, and mortality of neonatal and late-onset dilated cardiomyopathy associated with cardiac neonatal lupus

International Journal of Cardiology - Tập 248 - Trang 263-269 - 2017
Nathalie Morel1, Kateri Lévesque1, Alice Maltret2,3, Gabriel Baron4,3, Mohamed Hamidou5, Pauline Orquevaux6, Jean-Charles Piette7, François Barriere8, Jérôme Le Bidois2,3, Laurent Fermont2,3, Olivier Fain9, Arnaud Theulin10, François Sassolas11, Quentin Hauet12, Gaëlle Guettrot-Imbert1, Sophie Georgin-Lavialle13, Christophe Deligny14, Eric Hachulla15, Luc Mouthon1, Claire Le Jeunne1
1AP-HP, Hôpital Cochin, Centre de référence maladies auto-immunes et systémiques rares, Paris, France
2APHP, Centre de référence Malformations Cardiaques Congénitales Complexes - M3C, Hôpital Necker, Paris, France
3Université Paris Descartes, Sorbonne Paris Cité, Paris, France
4AP-HP, Hôpital Hôtel-Dieu, Centre d'Epidémiologie Clinique, Paris, France
5Service de médecine interne, CHU, Nantes, France
6CHU de Reims, Centre de compétence maladies auto-immunes et systémiques rares, Reims, France
7UPMC, AP-HP, Hôpital Pitié-Salpêtrière, Centre de référence maladies auto-immunes et systémiques rares, Paris, France
8AP-HM, Hôpital Timone Enfants, Unité de Réanimation Pédiatrique, Marseille, France
9UPMC, AP-HP, Hôpital Saint Antoine, Paris, France
10Rhumatologie, Centre de référence maladies auto-immunes et systémiques rares, Strasbourg, France
11Hôpital Louis Pradel, Lyon, France
12Unité Fonctionnelle de Cardiologie Pédiatrique et Congénitale, CHU Angers, France
13UPMC, Hôpital Tenon, Paris, France
14CHU Fort de France, Martinique, France
15Centre de référence maladies auto-immunes et systémiques rares, Lille, France

Tài liệu tham khảo

Costedoat-Chalumeau, 2005, Anti-SSA/Ro antibodies and the heart: more than complete congenital heart block? A review of electrocardiographic and myocardial abnormalities and of treatment options, Arthritis Res. Ther., 7, 69, 10.1186/ar1690 Guettrot-Imbert, 2011, A new presentation of neonatal lupus: 5 cases of isolated mild endocardial fibroelastosis associated with maternal anti-SSA/Ro and anti-SSB/La antibodies, J. Rheumatol., 38, 378, 10.3899/jrheum.100317 Moak, 2001, Congenital heart block: development of late-onset cardiomyopathy, a previously underappreciated sequela, J. Am. Coll. Cardiol., 37, 238, 10.1016/S0735-1097(00)01048-2 Nield, 2002, Endocardial fibroelastosis associated with maternal anti-Ro and anti-La antibodies in the absence of atrioventricular block, J. Am. Coll. Cardiol., 40, 796, 10.1016/S0735-1097(02)02004-1 Nield, 2002, Maternal anti-Ro and anti-La antibody-associated endocardial fibroelastosis, Circulation, 105, 843, 10.1161/hc0702.104182 Costedoat-Chalumeau, 2013, Letter to the Editor in response to the article “Preventing congenital neonatal heart block in offspring of mothers with anti-SSA/Ro and SSB/La antibodies: a review of published literature and registered clinical trials.” by Gleicher N, Elkayam U, Autoimmun. Rev., 12, 1039, 10.1016/j.autrev.2013.04.006 Morel, 2015, Neonatal lupus syndrome: literature review, Rev. Med. Interne, 36, 159, 10.1016/j.revmed.2014.07.013 Villain, 2006, Presentation and prognosis of complete atrioventricular block in childhood, according to maternal antibody status, J. Am. Coll. Cardiol., 48, 1682, 10.1016/j.jacc.2006.07.034 Brito-Zeron, 2015, The clinical spectrum of autoimmune congenital heart block, Nat. Rev. Rheumatol., 11, 301, 10.1038/nrrheum.2015.29 Udink ten Cate, 2001, Dilated cardiomyopathy in isolated congenital complete atrioventricular block: early and long-term risk in children, J. Am. Coll. Cardiol., 37, 1129, 10.1016/S0735-1097(00)01209-2 Costedoat-Chalumeau, 2004, Outcome of pregnancies in patients with anti-SSA/Ro antibodies: a study of 165 pregnancies, with special focus on electrocardiographic variations in the children and comparison with a control group, Arthritis Rheum., 50, 3187, 10.1002/art.20554 Brucato, 2001, Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women, Arthritis Rheum., 44, 1832, 10.1002/1529-0131(200108)44:8<1832::AID-ART320>3.0.CO;2-C Buyon, 2015, Predictors of pregnancy outcomes in patients with lupus: a cohort study, Ann. Intern. Med., 163, 153, 10.7326/M14-2235 Izmirly, 2012, Maternal use of hydroxychloroquine is associated with a reduced risk of recurrent anti-SSA/Ro-antibody-associated cardiac manifestations of neonatal lupus, Circulation, 126, 76, 10.1161/CIRCULATIONAHA.111.089268 Eronen, 2000, Short- and long-term outcome of children with congenital complete heart block diagnosed in utero or as a newborn, Pediatrics, 106, 86, 10.1542/peds.106.1.86 Lopes, 2008, Perinatal outcome of fetal atrioventricular block: one-hundred-sixteen cases from a single institution, Circulation, 118, 1268, 10.1161/CIRCULATIONAHA.107.735118 Taylor-Albert, 1997, Delayed dilated cardiomyopathy as a manifestation of neonatal lupus: case reports, autoantibody analysis, and management, Pediatrics, 99, 733, 10.1542/peds.99.5.733 Seko, 2007, A case of neonatal lupus erythematosus presenting delayed dilated cardiomyopathy with circulating autoantibody to annexin A6, Int. Heart J., 48, 407, 10.1536/ihj.48.407 Levesque, 2015, Description of 214 cases of autoimmune congenital heart block: results of the French neonatal lupus syndrome, Autoimmun. Rev., 14, 1154, 10.1016/j.autrev.2015.08.005 Eliasson, 2011, Isolated atrioventricular block in the fetus: a retrospective, multinational, multicenter study of 175 patients, Circulation, 124, 1919, 10.1161/CIRCULATIONAHA.111.041970 Saleeb, 1999, Comparison of treatment with fluorinated glucocorticoids to the natural history of autoantibody-associated congenital heart block: retrospective review of the research registry for neonatal lupus, Arthritis Rheum., 42, 2335, 10.1002/1529-0131(199911)42:11<2335::AID-ANR12>3.0.CO;2-3 Jaeggi, 2004, Transplacental fetal treatment improves the outcome of prenatally diagnosed complete atrioventricular block without structural heart disease, Circulation, 110, 1542, 10.1161/01.CIR.0000142046.58632.3A Izmirly, 2015, Assessment of fluorinated steroids to avert progression and mortality in anti-SSA/Ro-associated cardiac injury limited to the fetal conduction system, Ann. Rheum. Dis., 75, 1161, 10.1136/annrheumdis-2015-208311 Van den Berg, 2016, Fluorinated steroids do not improve outcome of isolated atrioventricular block, Int. J. Cardiol., 225, 167, 10.1016/j.ijcard.2016.09.119 Izmirly, 2011, Maternal and fetal factors associated with mortality and morbidity in a multi-racial/ethnic registry of anti-SSA/Ro-associated cardiac neonatal lupus, Circulation, 124, 1927, 10.1161/CIRCULATIONAHA.111.033894 Llanos, 2012, Anatomical and pathological findings in hearts from fetuses and infants with cardiac manifestations of neonatal lupus, Rheumatology (Oxford), 51, 1086, 10.1093/rheumatology/ker515 Khoshnood, 2016, Assessing sociodemographic differences (or lack thereof) in prenatal diagnosis of congenital heart defects: a population-based study, BMJ Open, 6, 10.1136/bmjopen-2015-009353 Casanova, 2015, Human genetic basis of interindividual variability in the course of infection, Proc. Natl. Acad. Sci. U. S. A., 112, E7118, 10.1073/pnas.1521644112 Tantengco, 2001, Left ventricular dysfunction after long-term right ventricular apical pacing in the young, J. Am. Coll. Cardiol., 37, 2093, 10.1016/S0735-1097(01)01302-X Janousek, 2013, Permanent cardiac pacing in children: choosing the optimal pacing site: a multicenter study, Circulation, 127, 613, 10.1161/CIRCULATIONAHA.112.115428 Kim, 2007, Ventricular function and long-term pacing in children with congenital complete atrioventricular block, J. Cardiovasc. Electrophysiol., 18, 373, 10.1111/j.1540-8167.2006.00741.x Thambo, 2004, Detrimental ventricular remodeling in patients with congenital complete heart block and chronic right ventricular apical pacing, Circulation, 110, 3766, 10.1161/01.CIR.0000150336.86033.8D